Cargando…
Efficacy and Safety of Bictegravir-Based Regimen in Pregnant Women Living with HIV: A Case Report
Bictegravir (BIC) is included in international guidelines as the first line of therapy for patients living with Human Immunodeficiency Virus (HIV), either as initial therapy or as a replacement for patients with prior antiretroviral therapy (ART). Due to limited efficacy and safety data, BIC is curr...
Autores principales: | Alsulami, Shaimaa, Alotaibi, Sultan N., Damfu, Nader, Aljefri, Doaa M., Altayib, Hadeel Ahmed, Alharbi, Maher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772963/ https://www.ncbi.nlm.nih.gov/pubmed/36529886 http://dx.doi.org/10.1177/23259582221146110 |
Ejemplares similares
-
606. Efficacy and Safety of Ceftazidime-Avibactam Comparative Dosage Regimens in Patients with Kidney Injury: A Retrospective Cohort Study
por: Sait, Walaa Adel, et al.
Publicado: (2022) -
Real-world efficacy and safety of switching to bictegravir/emtricitabine/tenofovir alafenamide in older people living with HIV
por: Rolle, Charlotte-Paige, et al.
Publicado: (2021) -
Meta-Analysis of Efficacy and Safety of Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide Among People Living with HIV
por: Chen, I-Wen, et al.
Publicado: (2021) -
Pharmacokinetics of Bictegravir in Older Japanese People Living with HIV-1
por: Kawashima, Akira, et al.
Publicado: (2023) -
Switching to a Bictegravir Single Tablet Regimen in Elderly People Living with HIV-1: Data Analysis from the BICTEL Cohort
por: Lazzaro, Alessandro, et al.
Publicado: (2021)